US Patent

US9138456 — Lipopeptide compositions and related methods

Formulation · Assigned to Cubist Pharmaceuticals LLC · Expires 2030-11-23 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects novel powder formulations of daptomycin, such as those containing daptomycin and sucrose, with improved stability and reconstitution times.

USPTO Abstract

The present disclosure provides novel powder daptomycin formulations which have improved chemical stability and faster reconstitution times when in the solid state. Some examples of the compositions comprise daptomycin and sucrose.

Drugs covered by this patent

Patent Metadata

Patent number
US9138456
Jurisdiction
US
Classification
Formulation
Expires
2030-11-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Cubist Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.